With several king bombs in hand, the next thing Wei Kang has to consider is the company's new business direction.
In the field of pharmaceuticals, the company's research and development capabilities are getting stronger and stronger. In addition to the drugs it extracts, its self-developed original drugs have already supported the industry.
Chronic nephritis drugs, asthma drugs, hypoglycemic drugs, and anti-inflammatory drugs, these four types of drugs have a relatively long history. There are a wide variety of drugs on the market, and they are all very mature and effective, not to mention low-priced generic drugs.
Especially for long-term medications like hypoglycemic drugs, price is the primary factor that patients consider, and they should also take medications according to their specific conditions.
The drugs launched by Sanqing are more effective and have fewer side effects, but in terms of efficacy, there is not a big gap, so they can only occupy a niche as original drugs and slowly seize the market.
It certainly cannot be as effective as anti-cancer drugs and AD specific drugs, killing everyone.
"That's all. Breakthrough innovative drugs are not just cabbage available everywhere."
"Fortunately, we have made great gains in medical devices, especially in the field of artificial organs. As long as artificial hearts can be created, Sanqing will become the undisputed king in the field of high-end consumables."
"In the future, there will be artificial livers, artificial kidneys, artificial lungs, artificial pancreas, etc. As technology continues to accumulate, we can even completely monopolize this market."
When Wei Kang thought of this, he couldn't help but be filled with pride and high morale.
Medical devices are divided into two categories: equipment and consumables.
Domestic equipment manufacturers have seized the mid- to low-end market and are gradually encroaching on the high-end market. The state has also provided various preferential policies to ensure the localization of medical equipment.
Although large-scale medical equipment worth tens of millions, such as CT, MRI, and medical linear accelerators, have not yet been domestically produced, major domestic manufacturers are eyeing this market and are gearing up and eager to give it a try.
Sanqing is also making efforts in the field of high-end equipment. After Weikang plans to win the endoscope market, it will enter the MRI field and win the peak of domestic MRI.
The same is true for consumables, but the situation is even more severe.
Because not every hospital has large-scale equipment worth tens of millions, nor does it need to be purchased every year.
However, the consumption of high-value consumables is huge and growing rapidly every year, so the market potential is huge.
Medical consumables are divided into high-value consumables, ordinary consumables and test reagents.
Artificial organs, cardiac interventional products, vascular interventional products, neurology interventional products, neurosurgery products such as dura mater, orthopedic materials and instruments, are all high-value consumables.
Two-thirds of high-value consumables are monopolized by international giants such as Medtronic, Johnson & Johnson, Bard, and St. Jude. Due to the high technical threshold, it will be difficult for domestic manufacturers to catch up in a short time.
The track belonging to domestic equipment manufacturers is in ordinary consumables, such as syringes, vacuum blood collection tubes, disposable anesthesia bags, etc., and they firmly occupy this market with high cost performance.
As for testing reagents, the concentration of the entire industry is relatively high. Well-known brands such as Roche, Siemens, Abbott, and Johnson & Johnson account for 60% of the in vitro diagnostic market and have obvious monopoly advantages.
In this regard, domestic manufacturers can only say that there is still a lot of room for growth.
In fact, in the entire domestic medical device industry, 80% of listed companies are engaged in diagnostic products, conventional medical consumables and medical devices.
There are very few manufacturers of therapeutic products, medical equipment, and innovative medical devices.
Because diagnostic products have a high usage rate, they can create better economic benefits for hospitals.
Relatively speaking, therapeutic products have higher clinical requirements and low usage. In the event of a medical accident, hospitals will often stop using them, so it is difficult to expand. The risks are high and the technical threshold is high, which makes manufacturers reluctant to invest in this area.
Sanqing is currently also focusing on diagnostic products and has performed well.
However, Wei Kang has greater ambitions and wants to move to higher places.
Nanorobots, artificial organs, MRI equipment, and surgical robots fall into four categories: therapeutic products, high-value consumables, medical equipment, and innovative equipment. They are also the future development direction of Sanqing in the field of medical equipment.
He must win these four most dazzling pearls one by one.
Of course, we are still a little far away from the goal, so we can only take it step by step.
NanoLab already has a product called nanopills, and the next goal is to carry forward this technology of targeted drug delivery and apply it to the treatment of other diseases.
On this basis, nanorobots with DNA molecular and protein molecular structures are created.
“In addition to antibiotics, for which other disease can nanotechnology be applied?”
"By the way, I remembered that there is a disease that is absolutely suitable for nanotechnology. If it can be successfully entered into the clinic, it will benefit hundreds of millions of patients."
Wei Kang suddenly had an idea in his mind and came up with an excellent target for nano pills.
"Oral insulin can achieve the same effect as injected insulin by wrapping the insulin molecules in nanoparticles, entering the bloodstream through the intestinal wall, and gathering in the liver, and is even better and more convenient."
“In this way, we will not only save hundreds of millions of diabetic patients, but also make a lot of money, and we don’t have to worry about points.”
Insulin is a small molecule protein containing 51 amino acids.
Insulin is a hormone that helps the body control the amount of glucose in the blood.
In healthy humans, beta cells in the pancreas secrete insulin when glucose levels in the blood rise.
Insulin's main target is the liver, where it removes glucose from the blood and converts it into glycogen or fat.
People with type I diabetes do not produce enough insulin, while people with type II diabetes have cells that become immune to insulin, so they need to monitor their blood sugar levels and give them insulin treatment.
For decades, pharmaceutical companies have been unable to produce an effective oral insulin formulation, despite their best efforts.
Because in the digestive tract, part of the insulin will be broken down by the digestive enzymes in the human body, and the remaining insulin will reach the intestines, and the intestinal wall is also a barrier that is difficult for them to cross.
Therefore, diabetics can only inject insulin every day, which is very painful.
However, there are also some complications when injecting insulin, some of which are even very serious and threaten the patient's life.
Because even if a drug is effective for a patient, it is very difficult to deliver it to the right location.
In fact, most side effects of any drug occur because the drug spreads to places where it is not needed.
Because most insulin agents do not reach the liver, patients experience numerous adverse effects when treated with insulin, including weight gain, microvascular disease, renal failure, cardiovascular complications, blindness, and even amputation.
In this case, if there is an oral insulin drug that can quickly and effectively pass through the intestinal wall, travel through the blood to the liver, and then release insulin molecules, it will perfectly solve this world problem.
There are 500 million diabetic patients in the world, and they are still growing rapidly every year. There are 130 million patients in China alone, which has become the biggest disease of wealth plaguing modern people.
“Compared with the current injected insulin, oral insulin is a huge blow in terms of ease of use and comfort, not to mention better efficacy and fewer complications.”
"If all 500 million people can use oral insulin, how many points will it cost?"
The more Wei Kang thought about it, the more excited he became. A huge golden mountain seemed to appear in front of his eyes. It was made up of points and could clear out the entire equipment mall.
Almost instantly, he made a decision.
"The project will be established in the next year. With the accumulation of nano-pill technology, oral insulin is still very promising. When it is actually launched, it will become the trump drug second only to anti-cancer drugs and AD specific drugs. Even genetic drugs will have to be ranked At the back.”
But then, he was a little worried. He felt that the scientific research strength of the nano laboratory was a bit weak, and he didn't know whether it could deal with such a problem.
"This is a self-research project of Sanqing. I wonder if the Nano Lab can handle it?"
"I remember that the person in charge of the nano-pill project is named Xue Shen. He is also a postdoctoral fellow in the field of nano-research. He has rich scientific research experience, so he should be able to do it."
"Let's do this. Give him some time first and trust your own scientific researchers."
"Sanqing has always spared no effort in cultivating talents. As long as they are truly capable, they will definitely succeed. This has been verified by many people."
"Wen Renlong, Chen Yiqing, Tang Que, Gu Xian, Lu Tingfeng, Sheng Changya, these people have never let me down, and I believe he will not either."
His consistent principle is to cultivate his own talents, even geniuses.
Only in this way can we establish a complete talent training and promotion system, so as to have a complete talent sequence. We must not think of poaching people from outside whenever we encounter difficulties.
"In addition to nanotechnology, we also need to build an artificial organ laboratory and we still need to recruit people."
After Wei Kang considered everything carefully, he assigned the projects one by one.
Sanqing currently adopts a flat management model. In addition to the laboratory to which it belongs, each project can also recruit project personnel from other departments or laboratories.
As long as the project requires it, genetic medicine projects can also be joined by mechanical engineers and even programmers.
Of course, he won't control it in such detail. He only needs to designate a few technical backbones and project leaders and grant them permissions.
The rest is left to the project leader, who only needs to verify the results.
This is the joy of being a boss.
The next days passed quickly.
The Spring Festival is here in a blink of an eye.
On New Year's Eve, Wei Kang took his father-in-law's family to Sanqingyuan and spent the New Year lively.
After dinner in the evening, the four of them sat together on the big sofa in the living room, watching the Spring Festival Gala, filled with laughter and laughter.
Wei Kang looked at the scene in front of him, the corners of his mouth couldn't help but turn up, and he felt a sweet smell of candy floating in the air.
The taste is very familiar, like the taste of the year in childhood memories.
However, it seems that something is missing.
He looked up at the ceiling and fell into memories. After thinking for a while, he finally realized it.
There are also missing the sounds of children running around, making noise and laughing.
After looking at Jian Lian Yun, who was clinging to him, he couldn't help but lean into his ear and whisper, "Do you feel like something is missing?"
Jian Jianyun looked confused and said, "Ah, are you missing something? Just make do with it, the store won't open until a few days later."
Wei Kang whispered: "Your parents will go back in two days. Such a big house always feels less popular, especially during the Chinese New Year. It always needs to be lively."
Jian Jian Yun looked at him confused: "What are you thinking about?"
Wei Kang chuckled: "I was thinking, if there are a few children, the Chinese New Year will be lively. Let's try hard to make the Chinese New Year a lively one next year, okay?"
Jian Jianyun's eyes widened and he exclaimed: "How many more do you want?"
Suddenly, Jian Guohua's cheerful voice came from the side: "It would be great to have more grandchildren. I have long wanted to hold grandchildren."
Jian Jianyun covered his face, feeling embarrassed and annoyed: "Dad, you actually eavesdropped on our conversation."
It turned out that the TV sound had been turned off long ago, and the whispers between the two people here were clearly heard.
Wei Kang turned around and looked at his father-in-law, and they both laughed at the same time.
(End of chapter)
